{"id":"NCT02616783","sponsor":"Gilead Sciences","briefTitle":"Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years","officialTitle":"A Phase 3b, Randomized, Open-Label Study to Evaluate Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Subjects Aged ≥ 60 Years","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-12-22","primaryCompletion":"2018-02-21","completion":"2018-03-21","firstPosted":"2015-11-30","resultsPosted":"2019-02-19","lastUpdate":"2020-03-04"},"enrollment":167,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["HIV-1 Infection"],"interventions":[{"type":"DRUG","name":"E/C/F/TAF","otherNames":["Genvoya®"]},{"type":"DRUG","name":"TDF","otherNames":["Viread®"]},{"type":"DRUG","name":"FTC","otherNames":["Emtriva®"]},{"type":"DRUG","name":"FTC/TDF","otherNames":["Truvada®"]},{"type":"DRUG","name":"3TC","otherNames":["Lamivudine","Epivir®"]},{"type":"DRUG","name":"Third agent","otherNames":[]}],"arms":[{"label":"E/C/F/TAF","type":"EXPERIMENTAL"},{"label":"Remain current regimen","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objective of this study is to evaluate the safety of elvitegravir/cobicistat/emtricitabine/ tenofovir alafenamide (E/C/F/TAF) relative to unchanged current antiretroviral therapy (ART) by assessing spine and hip bone mineral density (BMD) measured at Week 48 in virologically-suppressed, HIV-1 infected participants aged ≥ 60 years.","primaryOutcome":{"measure":"Percent Change From Baseline to Week 48 in Spine BMD","timeFrame":"Baseline; Week 48","effectByArm":[{"arm":"E/C/F/TAF","deltaMin":2.237,"sd":3.2727},{"arm":"Stay on Baseline Regimen","deltaMin":-0.104,"sd":3.3854}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"60 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":5},"locations":{"siteCount":35,"countries":["Belgium","France","Italy","Spain","United Kingdom"]},"refs":{"pmids":["31578954"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":110},"commonTop":["Nasopharyngitis","Vitamin D deficiency","Back pain","Diarrhoea","Bronchitis"]}}